AVNS VS NRC Stock Comparison

PerformanceSentimentTechnicalsEarningsProfitVolatilityDividend
PerformanceSentimentTechnicalsEarningsProfitVolatilityDividend

Performance

AVNS
10/100

AVNS returned -19.03% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

NRC
42/100

NRC returned 11.99% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 41 of 100.

Sentiment

AVNS
86/100

AVNS had a bullish sentiment score of 85.83% across Twitter and StockTwits over the last 12 months. It had an average of 1.00 posts, 0.00 comments, and 0.00 likes per day.

NRC
71/100

NRC had a bullish sentiment score of 70.68% across Twitter and StockTwits over the last 12 months. It had an average of 1.11 posts, 0.00 comments, and 0.00 likes per day.

Technicals

AVNS
61/100

AVNS receives a 60 of 100 based on 14 indicators. 8 are bullish, 5 are bearish.

NRC
10/100

NRC receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

AVNS
10/100

AVNS has missed earnings 6 times in the last 20 quarters.

NRC
100/100

NRC has missed earnings 0 times in the last 20 quarters.

Profit

AVNS
46/100

Out of the last 20 quarters, AVNS has had 8 profitable quarters and has increased their profits year over year on 7 of them.

NRC
62/100

Out of the last 20 quarters, NRC has had 20 profitable quarters and has increased their profits year over year on 6 of them.

Volatility

AVNS
46/100

AVNS has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

NRC
51/100

NRC has had a higher than average amount of volatility over the last 12 months giving it a score of 50 of 100.

Dividend

AVNS

"Dividend" not found for AVNS

NRC
100/100

NRC's most recent dividend was $0.13 per share, based on a share price of $41.18. It was a payout ratio of 53.95% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Avanos Medical, Inc. Summary

New York Stock Exchange / AVNS
Healthcare
Medical - Devices
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

National Research Corporation Common Stock (Delaware) Summary

Nasdaq / NRC
Healthcare
Medical - Healthcare Information Services
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.